Investors are continuing to pursue a securities misrepresentation lawsuit against Jiangsu Wu Zhong Pharmaceutical Development Co., Ltd. (referred to as: *ST Su Wu, Delisted Su Wu, stock code: 600200). Li Jian, a lawyer from Zhejiang Yufeng Law Firm representing some of the plaintiffs, stated that this week they have submitted litigation materials on behalf of another group of investors.

The case stems from an announcement made by *ST Su Wu on the evening of November 25, 2025, regarding the receipt of a "Administrative Penalty Decision" from the China Securities Regulatory Commission (CSRC). The announcement detailed the following established illegal activities: 1) Failure to truthfully disclose the actual controller, resulting in false records in the annual reports from 2018 to 2023; 2) Inflated operating revenue, operating costs, and profits, leading to false records in the annual reports from 2020 to 2023; 3) Failure to disclose related-party non-operational fund occupation as required, constituting major omissions in the annual reports from 2020 to 2023. The CSRC decided to order *ST Su Wu to make corrections, issue a warning, and impose a fine of 10 million yuan; warnings and respective fines were also imposed on the responsible individuals. Qian Qunshan was barred from the securities market for 10 years.

It is noteworthy that on December 30, 2025, *ST Su Wu announced the termination of its stock listing and delisting, with the delisting date set for December 31, 2025.

According to the judicial interpretation of the Supreme People's Court on securities misrepresentation, investors whose rights and interests are damaged due to such misrepresentation by listed companies can file lawsuits to claim compensation. The scope of compensation includes investment loss differentials, commission losses, and stamp duty losses.

"Delisting of a listed company does not affect investors' eligibility to claim compensation," stated Lawyer Li Jian. Based on the judicial interpretation, the provisional claim period is for investors who purchased *ST Su Wu shares between April 20, 2019, and February 26, 2025, and still held the shares at the market close on February 26, 2025. The final eligibility criteria are subject to court determination.

Investors seeking compensation need to provide documents including a securities account information inquiry statement, a stock transaction statement (from April 1, 2019, to the present), and contact information.